IPO Review

Kwick Forensic Solutions IPO Review 2026 — GMP +48%, Apply or Avoid?

Kwick Forensic Solutions IPO opens August 27, 2026. GMP +₹43 (+48%), est. listing ₹133. India's emerging forensic solutions company — full review, sector analysis, apply/avoid verdict.

I
IPOLyst Team

IPOLyst Editorial

Kwick Forensic Solutions IPO is one of the most interesting upcoming mainboard offerings of the week — and the grey market just sent a sharp signal. GMP surged from ₹15 to ₹43 in a single day on August 22, pushing the premium to +48% before the IPO even opens. With an estimated listing price of ₹133 against the issue price of ₹90, the grey market is pricing in nearly half-again the issue price. The IPO opens August 27 and closes August 31, 2026. Here is our full review.

Kwick Forensic Solutions IPO Review 2026 — GMP +₹43 (+48%), hero image showing grey market premium surge from ₹0 to ₹43 in 5 days before IPO opens
Kwick Forensic Solutions IPO Review 2026 — GMP +₹43 (+48%), hero image showing grey market premium surge from ₹0 to ₹43 in 5 days before IPO opens

Key IPO Details

  • Issue Price: ₹90 per share (Book Building Issue)
  • GMP (Grey Market Premium): +₹43 (+48%) as of August 22, 2026
  • Estimated Listing Price: ₹133
  • Face Value: ₹10 per share
  • IPO Open Date: August 27, 2026
  • IPO Close Date: August 31, 2026
  • Allotment Date: September 1, 2026
  • Refund / Demat Credit: September 2, 2026
  • Listing Date: September 3, 2026
  • Exchange: BSE (Mainboard)
  • QIB: 50% | NII: 15% | Retail: 35%
  • Registrar: Bigshare Services Pvt. Ltd.

About Kwick Forensic Solutions

Kwick Forensic Solutions is an Indian company operating in the forensic services and solutions space — a niche but rapidly expanding sector driven by increasing demand from law enforcement agencies, government bodies, corporates, and legal institutions. The forensic industry in India has historically been underpenetrated, relying largely on government-run labs. Private forensic service providers like Kwick are emerging to fill critical gaps in speed, specialisation, and turnaround time.

The company's name — "Kwick" — signals a focus on speed and efficiency, positioning the business as a fast-turnaround forensic solutions provider. This is particularly relevant in India's legal and corporate investigation landscape, where time-sensitive forensic evidence is increasingly critical for litigation, insurance claims, regulatory compliance, and criminal investigations.

India's forensic sector encompasses digital forensics, document examination, fingerprint analysis, chemical and toxicological testing, cyber forensics, and expert witness services. As regulatory scrutiny of corporates increases and cybercrime rises, demand for private forensic services is growing rapidly. The company's IPO on the mainboard signals ambitions for a larger operational footprint and capital-backed growth.

The IPO includes an Offer for Sale of approximately 10,80,000 equity shares by existing shareholders. The OFS component indicates existing investors are using the listing to partially monetise their holdings. Investors should review the DRHP for the fresh issue component, planned use of proceeds, and post-IPO promoter holding levels.

GMP Analysis — The Sharp Signal You Should Not Miss

The GMP movement for Kwick Forensic Solutions is notable for its speed rather than its duration. Here is the full grey market history from Sanity data:

  • August 18: GMP ₹0 (0%) — no grey market signal
  • August 19: GMP ₹0 (0%) — still inactive
  • August 20: GMP +₹15 — first grey market activity appears
  • August 21: GMP +₹15 — stable, confirmation signal
  • August 22: GMP +₹43 (+48%) — sharp jump today, nearly 3× overnight

The key observation here is the nature of this move: from ₹15 to ₹43 in a single session on August 22 — a near-tripling of the grey market premium in one day. This kind of single-session surge typically reflects a sudden re-rating by grey market participants, often triggered by wider awareness, institutional interest, or information about subscription appetite from anchor investors or HNI networks.

A 48% GMP before the subscription even opens is one of the strongest percentage premiums in the current week's IPO lineup. At the issue price of ₹90, the grey market is pricing an estimated listing of ₹133 — a ₹43 premium. For retail investors, this means potential listing gains of ₹43 per share on an investment at ₹90, assuming the GMP holds through subscription and allotment.

As always: GMP is an informal indicator only. It can change significantly between today and the listing date of September 3, 2026. The final listing price will depend on actual subscription levels, QIB participation, market conditions on listing day, and broader market sentiment. Apply based on your own research — do not treat GMP alone as a buy signal.

Why Forensic Solutions Is a Hot Sector Right Now

India's forensic services market is at an inflection point driven by three structural forces: rising cybercrime, increasing corporate litigation, and government investment in forensic infrastructure. Let us look at each:

Rising Cybercrime and Digital Forensics Demand

India reported over 15 lakh cybercrime cases in 2023, growing at a compounded rate that law enforcement agencies are struggling to manage. Corporate data breaches, financial fraud, phishing, and ransomware attacks are driving demand for digital forensics — the fastest-growing sub-segment of the forensic industry. Private forensic firms with speed and specialisation have a significant advantage over government labs in serving corporate and legal clients under tight timelines.

According to the National Crime Records Bureau (NCRB), India reported over 15 lakh cybercrime cases in 2023 — and the numbers have continued to grow year-on-year. Law enforcement agencies, courts, and corporate investigation teams rely on accredited forensic analysis to build legally admissible evidence in these cases, creating sustained demand for private forensic service providers with fast turnaround capability.

Expanding Corporate and Legal Use Cases

India's Insolvency and Bankruptcy Code (IBC), SEBI's enforcement actions, and the rise of corporate investigations driven by ESG compliance and M&A due diligence are creating substantial demand for third-party forensic services. Law firms, insurance companies, banks, and large corporates are increasingly using forensic experts for document verification, fraud investigation, and regulatory compliance support.

Government Investment in Forensic Infrastructure

The Government of India has announced plans to modernise forensic labs under the National Forensic Science University (NFSU) framework and is expanding the mandate of state forensic labs. This creates both direct contract opportunities for private forensic firms and a structural tailwind for the sector as a whole, increasing market awareness and demand for forensic services.

For data on how institutional investors are positioning in the forensic services and technology space, the IPOLyst Smart Money Tracker tracks FII and DII bulk deal activity across NSE-listed companies.

India's forensic services industry operates under multiple regulatory frameworks. The National Forensic Science University (NFSU) is the apex institution for forensic science education and standards in India, and its expanding mandate reflects the government's focus on building forensic capacity.

Strengths

  • Niche Sector Positioning: Forensic solutions is a high-barrier, high-value services sector with limited organised private players. Kwick's positioning in this niche gives it potential pricing power and a differentiated competitive position relative to commodity service businesses.
  • Timing Advantage — Pre-Market Phase: The Indian private forensic services market is in its early growth phase. Companies entering now can establish brand recognition, client relationships, and regulatory approvals before the segment becomes crowded. First-mover advantage in a specialised services niche has historically led to durable market share.
  • Government and Corporate Demand Tailwinds: Increasing regulatory enforcement, rising cybercrime, and the expansion of India's legal framework around digital evidence are structural demand drivers that will sustain growth in forensic services for the next decade.
  • Mainboard Listing at ₹90: The relatively accessible issue price of ₹90 means a lower minimum investment per lot compared to many mainboard IPOs, potentially broadening the retail investor base and subscription interest.
  • Sharp Pre-Open GMP Signal: GMP surging from ₹15 to ₹43 (+48%) in a single session before subscription opens is one of the strongest percentage moves in the current cycle. This reflects concentrated grey market conviction about listing performance.

Risks

  • Limited Public Financial Disclosure: Issue size and detailed financials are not yet fully available in the public domain at the time of writing. Investors should review the DRHP filed with SEBI before making any application decisions. Operating in a niche market does not guarantee strong financials.
  • Sector Scalability Questions: Forensic services are inherently people-driven and expertise-dependent. Unlike technology products, scaling a forensic services business requires hiring qualified forensic experts — a constrained talent pool in India — which can limit growth velocity and margin expansion.
  • OFS Component: The IPO includes an Offer for Sale of approximately 10,80,000 shares by existing shareholders. This portion of proceeds goes to selling shareholders, not to the company. Investors should assess the size of the fresh issue relative to total issue size and the planned use of capital.
  • Grey Market Concentration Risk: The GMP is currently sourced from a limited number of grey market channels. A GMP based on thin grey market activity can reverse quickly. The sharp single-day jump from ₹15 to ₹43 should be interpreted with caution — verify across multiple grey market sources before the subscription window opens.
  • Market Risk on Listing Day: September 3, 2026 is approximately 11 days away. A significant market downturn between now and listing can compress actual listing gains even when GMP signals are strong. Always size your IPO applications within your risk tolerance.

How to Apply for Kwick Forensic Solutions IPO

Application Window

The IPO opens August 27, 2026 and closes August 31, 2026. Applications can be submitted through any ASBA-enabled bank account or via UPI on your brokerage platform. Check your broker's platform for the confirmed lot size and minimum application amount closer to the opening date.

Key Dates

  • IPO Open: August 27, 2026
  • IPO Close: August 31, 2026
  • Allotment Date: September 1, 2026
  • Refund / Demat Credit: September 2, 2026
  • Listing on BSE: September 3, 2026

Track live GMP, subscription status, and allotment results for Kwick Forensic Solutions at the IPOLyst GMP Tracker — updated multiple times daily during active IPOs.

View all IPOs opening this week alongside Kwick on the IPOLyst upcoming IPO calendar — includes Skyways Air Services, Lumino Industries, and more.

IPO Verdict — Apply or Avoid?

Kwick Forensic Solutions is a genuinely interesting IPO for two reasons: the sector and the GMP signal. Forensic solutions is one of the few truly niche sectors going public on the mainboard this cycle — in a market where most IPOs are manufacturing, pharma, or fintech, a forensic services company is a differentiated listing worth paying attention to.

The grey market signal is strong. A 48% GMP before the IPO even opens — with a sharp ₹15 to ₹43 move in a single day — reflects genuine grey market conviction. At ₹90 per share with an estimated listing of ₹133, the math on listing gains is compelling if the GMP holds.

The risks are real: limited public financials at this stage, a people-dependent business model that limits scaling velocity, and a sharp GMP move that could be based on thin grey market liquidity. These are not reasons to avoid — they are reasons to size your application appropriately rather than going all-in.

Our view: Apply for listing gains. The GMP signal is strong, the sector is genuinely interesting, and the accessible issue price of ₹90 makes this an attractive risk-reward for retail applicants. For long-term holding, wait for the post-listing period to assess actual financials and business performance before adding to any position.

Track live GMP and subscription data at ipolyst.com.

Kwick Forensic Solutions IPO — Frequently Asked Questions

Is Kwick Forensic Solutions IPO good for listing gains?

The pre-open GMP signal is one of the strongest in the current week's lineup — +₹43 (+48%) as of August 22, before the subscription even opens. GMP surged from ₹15 to ₹43 in a single session, suggesting a sharp re-rating by grey market participants. Estimated listing price is ₹133 against issue price ₹90. However, GMP is informal and can change — verify across sources and review the DRHP before applying.

What does Kwick Forensic Solutions do?

Kwick Forensic Solutions is an Indian forensic services company providing solutions in the forensic analysis and investigation space. The company serves law enforcement, corporate, legal, and government clients requiring fast, professional forensic analysis — including digital forensics, document examination, and related services.

When does Kwick Forensic Solutions IPO open?

Kwick Forensic Solutions IPO opens August 27, 2026 and closes August 31, 2026. Allotment is on September 1, 2026, with listing on BSE on September 3, 2026.

What is the issue price for Kwick Forensic Solutions IPO?

The issue price is ₹90 per share (Book Building Issue), with a face value of ₹10 per share. The lot size and exact minimum investment will be confirmed on your broker's platform closer to the opening date. Check ipolyst.com for live updates.

Kwick Forensic Solutions is one of several high-GMP IPOs opening this week. Compare it with Symbiotec Pharmalab and Skyways Air Services on the IPOLyst upcoming IPO calendar — all subscription dates, GMP trends, and allotment trackers in one place.

Disclaimer: This review is for informational and educational purposes only and does not constitute financial advice. IPOLyst is not a SEBI-registered investment advisor. GMP is indicative only and sourced from informal grey market channels. Financial details not yet confirmed in the public domain are noted as such — investors must review the DRHP filed with SEBI before making any investment decisions.